Amy A Kirkwood
Overview
Explore the profile of Amy A Kirkwood including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
816
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dulobdas V, Kirkwood A, Serpenti F, Gautama B, Panopoulou A, Mathew A, et al.
Blood Cancer J
. 2025 Mar;
15(1):30.
PMID: 40032870
CAR T-cell manufacturing failure (MF) is a situation where the manufacturing process fails to yield a product or results in one which is out-of-specification (OOS). We conducted a multicentre retrospective...
2.
Sesques P, Kirkwood A, Kwon M, Rejeski K, Jain M, Di Blasi R, et al.
J Hematol Oncol
. 2024 Aug;
17(1):61.
PMID: 39107847
Autologous anti-CD19 chimeric antigen receptor (CAR) T cells are now used in routine practice for relapsed/refractory (R/R) large B-cell lymphoma (LBCL). Severe (grade ≥ 3) cytokine release syndrome (CRS) and...
3.
Results from UKALL60+, a phase 2 study in older patients with untreated acute lymphoblastic leukemia
Patel B, Kirkwood A, Rowntree C, Alapi K, Barretta E, Clifton-Hadley L, et al.
Hemasphere
. 2024 Jun;
8(6):e88.
PMID: 38846719
No abstract available.
4.
Malaih A, Kirkwood A, Johnson P, Radhakrishnan V, Fischer B, Barrington S
Sci Rep
. 2024 Jun;
14(1):12613.
PMID: 38824206
The aim of the study was to assess healthy tissue metabolism (HTM) using 2-deoxy-2-[F]fluoro-D-glucose ([F]FDG) positron emission tomography/computed tomography (PET/CT) during chemotherapy in Hodgkin lymphoma (HL) and the association of...
5.
Oporto Espuelas M, Burridge S, Kirkwood A, Bonney D, Watts K, Shenton G, et al.
Blood Cancer J
. 2024 Apr;
14(1):66.
PMID: 38622139
CAR T-cell therapy has transformed relapsed/refractory (r/r) B-cell precursor acute lymphoblastic leukaemia (B-ALL) management and outcomes, but following CAR T infusion, interventions are often needed. In a UK multicentre study,...
6.
Bourlon C, Roddie C, Menne T, Norman J, OReilly M, Gibb A, et al.
Haematologica
. 2024 Apr;
109(8):2716-2720.
PMID: 38572567
No abstract available.
7.
Khwaja J, Ravichandran S, Bomsztyk J, Cohen O, Foard D, Martinez-Naharro A, et al.
Haematologica
. 2024 Jan;
109(5):1598-1602.
PMID: 38205538
No abstract available.
8.
Enshaei A, Joy M, Butler E, Kirkwood A, Messina M, Pavoni C, et al.
Blood Adv
. 2023 Dec;
8(5):1155-1166.
PMID: 38113467
Risk stratification is crucial to the successful treatment of acute lymphoblastic leukemia (ALL). Although numerous risk factors have been identified, an optimal prognostic model for integrating variables has not been...
9.
Poynton E, Chernucha E, Day J, Prodger C, Hopkins D, Rakesh P, et al.
Blood Adv
. 2023 Dec;
8(7):1772-1775.
PMID: 38039509
No abstract available.
10.
Wilson M, Kirkwood A, Doo N, Soussain C, Choquet S, Lees C, et al.
Am J Hematol
. 2023 Dec;
99(2):E46-E50.
PMID: 38037530
No abstract available.